The FDA has even authorised a drug designed with cannabidiol for that function (Epidiolex). Nevertheless the agency only suggests it for two rare kinds of childhood epilepsy termed Lennox-Gastaut syndrome and Dravet syndrome. Studies involving animals have demonstrated that THC may adversely have an effect on the immune program by https://thcamakesyouhigh52444.bloggazza.com/34167842/mind-altering-cannabis-compounds-fundamentals-explained